ReShape Lifesciences, a weight loss and metabolic health-solutions company to merge with clinical stage specialty pharmaceutical company Vyome, and acquire assets of metabolic health Biorad Medisys
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, and Vyome Therapeutics,